---
figid: PMC3615879__ott-6-243Fig4
figlink: /pmc/articles/PMC3615879/figure/f4-ott-6-243/
number: F4
caption: 'Proposed mechanism of action of 20-HETE.Notes: Mitogens and ligands of G-protein-coupled
  receptors activate PLA2 and induce release of arachidonic acid, which is converted
  by CYP4A/F to 20-HETE. Then, 20-HETE, acting presumably via Src, promotes tyrosine
  phosphorylation of EGFR and consequently activates the Ras-Raf-MEK-ERK cascade,
  which leads to the proliferation of cancer cells. One of cytoplasmic targets of
  ERK is I-kappaB kinase-alpha, which phosphorylates I-kappaB-alpha, resulting in
  the degradation of I-kappaB-alpha by the proteosome and the translocation of NFκB
  to the nucleus, where it positively regulates the transcription of a number of genes
  involved in immune and inflammatory responses including vEGF. In addition, 20-HETE
  also activates cAMP-dependent PKA-phosphorylase kinase-GP (glycogen phosphorylase
  pathway) to induce hyperglycemia. Besides, 20-HETE stimulates NADPH oxidase-derived
  superoxide production, which activates L-type Ca2+ channels via a PKC-dependent
  mechanism. Inhibitory interactions are shown by red lines with bars. Stimulatory
  interactions are shown by green lines with arrows. Activation of the principal signaling
  cascade is shown by +.Abbreviations: 20-HETE, 20-hydroxyeicosatetraenoic acid; GPCR,
  G protein-coupled receptor; EGFR, endothelial growth factor; PLA2, phospholipase
  A2; NADPH, nicotinamide adenine dinucleotide phosphate; SOS, salt overly sensitive;
  AA, arachidonic acid; CYP, cytochrome P450; PKC, protein kinase C; PKA, protein
  kinase A; PhK, phosphorylase kinase; GP, glycogen phosphorylase pathway; cAMP, cyclic
  adenosine monophos phate; MEK, MAP kinase kinase; ERK, extracellular signal-regulated
  kinases; IκBα, I-kappaB-alpha; NFκB, nuclear factor-kappaB; VEGF, vascular endothelial
  growth factor; HET0016, N-Hydroxy-N′-(4-butyl-2-methylphenyl) formamidine; WIT002,
  20-hydroxyeicosa-6(Z),15(Z)-dienoic acid.'
pmcid: PMC3615879
papertitle: Targeting 20-HETE producing enzymes in cancer – rationale, pharmacology,
  and clinical potential.
reftext: Anna Alexanian, et al. Onco Targets Ther. 2013;6:243-255.
pmc_ranked_result_index: '93575'
pathway_score: 0.9391744
filename: ott-6-243Fig4.jpg
figtitle: 'Action of 20-HETE.Notes: Mitogens and ligands of G-protein-coupled receptors
  activate PLA2 and induce release of arachidonic acid, which is converted by CYP4A/F
  to 20-HETE'
year: '2013'
organisms: Homo sapiens
ndex: 71e9d965-df06-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3615879__ott-6-243Fig4.html
  '@type': Dataset
  description: 'Proposed mechanism of action of 20-HETE.Notes: Mitogens and ligands
    of G-protein-coupled receptors activate PLA2 and induce release of arachidonic
    acid, which is converted by CYP4A/F to 20-HETE. Then, 20-HETE, acting presumably
    via Src, promotes tyrosine phosphorylation of EGFR and consequently activates
    the Ras-Raf-MEK-ERK cascade, which leads to the proliferation of cancer cells.
    One of cytoplasmic targets of ERK is I-kappaB kinase-alpha, which phosphorylates
    I-kappaB-alpha, resulting in the degradation of I-kappaB-alpha by the proteosome
    and the translocation of NFκB to the nucleus, where it positively regulates the
    transcription of a number of genes involved in immune and inflammatory responses
    including vEGF. In addition, 20-HETE also activates cAMP-dependent PKA-phosphorylase
    kinase-GP (glycogen phosphorylase pathway) to induce hyperglycemia. Besides, 20-HETE
    stimulates NADPH oxidase-derived superoxide production, which activates L-type
    Ca2+ channels via a PKC-dependent mechanism. Inhibitory interactions are shown
    by red lines with bars. Stimulatory interactions are shown by green lines with
    arrows. Activation of the principal signaling cascade is shown by +.Abbreviations:
    20-HETE, 20-hydroxyeicosatetraenoic acid; GPCR, G protein-coupled receptor; EGFR,
    endothelial growth factor; PLA2, phospholipase A2; NADPH, nicotinamide adenine
    dinucleotide phosphate; SOS, salt overly sensitive; AA, arachidonic acid; CYP,
    cytochrome P450; PKC, protein kinase C; PKA, protein kinase A; PhK, phosphorylase
    kinase; GP, glycogen phosphorylase pathway; cAMP, cyclic adenosine monophos phate;
    MEK, MAP kinase kinase; ERK, extracellular signal-regulated kinases; IκBα, I-kappaB-alpha;
    NFκB, nuclear factor-kappaB; VEGF, vascular endothelial growth factor; HET0016,
    N-Hydroxy-N′-(4-butyl-2-methylphenyl) formamidine; WIT002, 20-hydroxyeicosa-6(Z),15(Z)-dienoic
    acid.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PRKCQ
  - PRKCG
  - PRKCZ
  - CALM1
  - PRKCI
  - PRKCE
  - PRKCH
  - SHC2
  - PLA2G5
  - PRKACA
  - NRAS
  - PLA2G2A
  - PLA2G4A
  - PRKCD
  - PLA2G1B
  - HRAS
  - KRAS
  - PHKG2
  - PHKB
  - PHKA2
  - SHC4
  - PHKG1
  - SRC
  - PRKAR2A
  - PLA2G3
  - PLA2G7
  - PHKA1
  - BRAF
  - PRKAR1A
  - RELA
  - PLA2G2D
  - PRKACG
  - PRKCA
  - REL
  - RELB
  - CHUK
  - PLA2G2F
  - PLA2G12A
  - PRKACB
  - PRKAR2B
  - PRKCB
  - PLA2G2C
  - NFKB2
  - NFKBIA
  - PLA2G4D
  - PRKD3
  - SOS2
  - PRKAR1B
  - GRB2
  - SHC3
  - RAF1
  - NFKB1
  - PLA2G2E
  - ARAF
  - SHC1
  - SOS1
  - PLA2G10
  - PLA2G12B
  - PLA2G4C
  - NMUR1
  - PLA2G6
  - EGFR
  - Cancer
  - Noonan syndrome
genes:
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: PhK
  symbol: PhK
  source: bioentities_symbol
  hgnc_symbol: CALM1
  entrez: '801'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: Shc
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC2
  entrez: '25759'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G5
  entrez: '5322'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACA
  entrez: '5566'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G2A
  entrez: '5320'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G4A
  entrez: '5321'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G1B
  entrez: '5319'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: PhK
  symbol: PhK
  source: bioentities_symbol
  hgnc_symbol: PHKG2
  entrez: '5261'
- word: PhK
  symbol: PhK
  source: bioentities_symbol
  hgnc_symbol: PHKB
  entrez: '5257'
- word: PhK
  symbol: PhK
  source: bioentities_symbol
  hgnc_symbol: PHKA2
  entrez: '5256'
- word: Shc
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC4
  entrez: '399694'
- word: PhK
  symbol: PhK
  source: bioentities_symbol
  hgnc_symbol: PHKG1
  entrez: '5260'
- word: Src
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2A
  entrez: '5576'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G3
  entrez: '50487'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G7
  entrez: '7941'
- word: PhK
  symbol: PhK
  source: bioentities_symbol
  hgnc_symbol: PHKA1
  entrez: '5255'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1A
  entrez: '5573'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G2D
  entrez: '26279'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACG
  entrez: '5568'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: IKKA
  symbol: IKK-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G2F
  entrez: '64600'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G12A
  entrez: '81579'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACB
  entrez: '5567'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2B
  entrez: '5577'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G2C
  entrez: '391013'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: IKBA
  symbol: IkappaBalpha
  source: hgnc_alias_symbol
  hgnc_symbol: NFKBIA
  entrez: '4792'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G4D
  entrez: '283748'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: sos
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1B
  entrez: '5575'
- word: Grb2
  symbol: GRB2
  source: hgnc_symbol
  hgnc_symbol: GRB2
  entrez: '2885'
- word: Shc
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC3
  entrez: '53358'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G2E
  entrez: '30814'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Shc
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC1
  entrez: '6464'
- word: sos
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G10
  entrez: '8399'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G12B
  entrez: '84647'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G4C
  entrez: '8605'
- word: GPCR
  symbol: GPC-R
  source: hgnc_alias_symbol
  hgnc_symbol: NMUR1
  entrez: '10316'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G6
  entrez: '8398'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC3615879__F4
redirect_from: /figures/PMC3615879__F4
figtype: Figure
---
